中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Menu
Issue 6
Jun.  2012
Turn off MathJax
Article Contents
References
Article Navigation >  Journal of Clinical Hepatology  > 2012  >  28(6): 413-416+421

Prevalence of hepatitis B virus infection

  • Published Date: 2012-06-20
    Abstract
    • FullText(HTML)
    • References(49)
  • [1]Poynard T, Yuen MF, Ratziu V, et al.Viral hepatitis C[J].Lan-cet, 2003, 362:2095-2100.
    [2]Liang X, Bi S, Yang W, et al.Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination[J].Vaccine, 2009, 27 (47) :6550-6557.
    [3]Zhang H, Li Q, Sun J, et al.Seroprevalence and risk factors for hepatitis B infection in an adult population in Northeast China[J].Int J Med Sci, 2011, 8 (4) :321-331.
    [4] Okamoto H, Tsuda F, Sakugawa H, et al.Typing hepatitis B virus by homology in nucleotide sequence:comparison of surface antigen subtypes[J].J Gen Virol, 1988, 69 (Pt10) :2575-2583.
    [5]Stuyver L, De Gendt S, Van Geyt C, et al.A new genotype of hep-atitis B virus:complete genome and phylogenetic relatedness[J].J Gen Virol, 2000, 81 (Pt1) :67-74.
    [6]Magnius LO, Norder H.Subtypes, genotypes and molecular epide-miology of the hepatitis B virus as reflected by sequence variability of the S-gene[J].Intervirology, 1995, 38 (1-2) :24-34.
    [7] Norder H, Courouce AM, Magnius LO.Complete genomes, phylo-genetic relatedness, and structural proteins of six strains of the hepa-titis B virus, four of which represent two new genotypes[J].Virolo-gy, 1994, 198 (2) :489-503.
    [8]Takahashi K, Akahane Y, Hino K, et al.Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients:comparative analysis of40full-length isolates[J].Arch Virol, 1998, 143 (12) :2313-2326.
    [9]Arauz-Ruiz P, Norder H, Robertson BH, et al.Genotype H:a new Amerindian genotype of hepatitis B virus revealed in Central America[J].J Gen Virol, 2002, 83 (Pt8) :2059-2073.
    [10]Zeng G, Wang Z, Wen S, et al.Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China[J].J Viral Hepat, 2005, 12 (16) :609-617.
    [11]Kao JH, Chen PJ, Lai MY, et al.Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B[J].Gas-troenterology, 2000, 118 (3) :554-559.
    [12]Kobayashi M, Arase Y, Ikeda K, et al.Clinical characteristics of patients infected with hepatitis B virus genotypes A, B, and C[J].J Gastroenterol, 2002.37 (1) :35-39.
    [13]Ding X, Mizokami M, Yao G, et al.Hepatitis B virus genotype dis-tribution among chronic hepatitis B virus carriers in Shanghai, China[J].Intervirology, 2001, 44 (1) :43-47.
    [14]Thakur V, Guptan RC, Kazim SN, et al.Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent[J].J Gastroenterol Hepatol, 2002, 17 (2) :165-170.
    [15]Devarbhavi HC, Cohen AJ, Patel R, et al.Preliminary results:outcome of liver transplantation for hepatitis B virus varies by hepa-titis B virus genotype[J].Liver Transpl, 2002, 8 (6) :550-555.
    [16]Zollner B, Petersen J, Schroter M, et al.20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw[J].Lan-cet, 2001, 357 (9260) :934-935.
    [17]Norder H, Courouce AM, Coursaget P, et al.Genetic diversity of hepatitis B virus strains derived worldwide:genotypes, subgeno-types, and HBsAg subtypes[J].Intervirology, 2004, 47 (6) :289-309.
    [18]许军, 王齐欣, 范春蕾, 等.中国南北两城市乙型肝炎病毒基因型与血清型的构成差异[J].中华实验和临床病毒学杂志, 2003, 17 (4) :327-329.
    [19]Gutierrez-Garcia ML, Fernandez-Rodriguez CM, Lledo-Navarro JL, et al.Prevalence of occult hepatitis B virus infection[J].World J Gastroenterol, 2011, 17 (2) :1538-1542.
    [20]Fang Y, Shang QL, Liu JY, et al.Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China[J].J Infect, 2009, 58 (5) :383-388.
    [21]Hollinger FB.Hepatitis B virus infection and transfusion medicine:science and the occult[J].Transfusion, 2008, 48 (5) :1001-1026.
    [22]Linauts S, Saldanha J, Strong DM.PRISM hepatitis B surface anti-gen detection of hepatits B virus minipool nucleic acid testing yield samples[J].Transfusion, 2008, 48 (7) :1376-1382.
    [23]Hourfar MK, Jork C, Schottstedt V, et al.Experience of German Red Cross blood donor services with nucleic acid testing:results of screening more than30million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus[J].Transfusion, 2008, 48 (8) :1558-1566.
    [24]Hui CK, Sun J, Au WY, et al.Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area[J].J Hepatol, 2005, 42 (6) :813-819.
    [25]Guan R, Lui HF.Treatment of hepatitis B in decompensated liver cirrhosis[J].Int J Hepatol, 2011, 2011:918017.[Epub2011Jun23]
    [26]Proceedings of the European Association for the Study of the Liver (EASL) International Consensus Conference on Hepatitis B.Sep-tember14-16, 2002.Geneva, Switzerland[J].J Hepatol, 2003, 39 (Suppl1) :S1-235.
    [27]Liaw YF, Leung N, Kao JH, et al.Asian-Pacific consensus state-ment on the management of chronic hepatitis B:a2008update[J].Hepatol Int, 2008, 2 (3) :263-283.
    [28]Parkin DM, Bray F, Ferlay J, et al.Global cancer statistics, 2002[J].CA Cancer J Clin, 2005, 55:74-108.
    [29]Raza SA, Clifford GM, Franceschi S.Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepato-cellular carcinoma:a systematic review[J].Br J Cancer, 2007, 96 (7) :1127-34.
    [30]Bertuccio P, Chatenoud L, Levi F, et al.Recent patterns in gastric cancer:a global overview[J].Int J Cancer, 2009, 125 (3) :666-673.
    [31] Liang X, Bi S, Yang W, et al.Evaluation of the impact of hepatitis B vaccination among children born during1992-2005in China[J].J Infect Dis, 2009, 200 (1) :39-47.
    [32]Helcl J, CástkováJ, Benes C, et al.Control of occupational hepa-titisB among health care workers in the Czech Republic;1982to 1995[J].Infect Control HosP EPid emiol, 2000, 21 (5) :343-346.
    [33]Denes AE, Smith JL, Maynard JE, et al.Hepatitis B infection in physicians.Results of a nationwide seroepidemiologic survey[J].JAMA, 1978, 239 (3) :210-212.
    [34]Kosgeroglu N, Ayranci U, Vardareli E, et al.Occupational expo-sure to hepatitis infection among Turkish nurses:frequency of nee-dle exposure, sharps injuries and vaccination[J].Epidemiol In-fect, 2004, 132 (1) :27-33.
    [35]Todd CS, Nasir A, Stanekzai MR, et al.HIV, hepatitis B, and hepatitis C prevalence and associated risk behaviors among female sex workers in three Afghan cities[J].AIDS, 2010, 24 (Suppl2) :S69-75.
    [36]Pinarbasi B, Onel D, Cosan F, et al.Prevalence and virological features of occult hepatitis B virus infection in female sex workers who work uncontrolled in Turkey[J].Liver Int, 2009, 29 (2) :227-230.
    [37]Gutierrez M, Tajada P, Alvarez A, et al.Prevalence of HIV-1 non-B subtypes, syphilis, HTLV, and hepatitis B and C viruses among immigrant sex workers in Madrid, Spain[J].J Med Virol, 2004, 74 (4) :521-527.
    [38]Camejo MI, Mata G, Díaz M.Prevalence of hepatitis B, hepatitis C and syphilis in female sex workers in Venezuela[J].Rev Saude Publi-ca, 2003, 37 (3) :339-344.
    [39]Mak R, Traen A, Claeyssens M, et al.Hepatitis B vaccination for sex workers:do outreach programmes perform better?[J].Sex Transm Infect, 2003, 79 (2) :157-159.
    [40]Ishi K, Suzuku F, Saito A, et al.Prevalence of human immunodefi-ciency virus, hepatitis B and hepatitis C virus antibodies and hepatitis B antigen among commercial sex workers in Japan[J].Infect Dis Ob-stet Gynecol, 2001, 9 (4) :215-219.
    [41]Forbi JC, Onyemauwa N, Gyar SD, et al.High prevalence of hepa-titis B virus among female sex workers in Nigeria[J].Rev Inst Med Trop Sao Paulo, 2008, 50 (4) :219-221.
    [42]Sandesh K, Varghese T, Harikumar R, et al.Prevalence of Hepatitis B and C in the normal population and high risk groups in north Kerala[J].Trop Gastroenterol, 2006, 27:80-83.
    [43]Ruan Y, Luo F, Jia Y, et al.Risk factors for syphilis and preva-lence of HIV, hepatitis B and C among men who have sex with men in Beijing, China:implications for HIV prevention[J].AIDS Be-hav, 2009, 13 (4) :663-670.
    [44]Sa-Nguanmoo P, Tangkijvanich P, Thawornsuk N, et al.Molecu-lar epidemiological study of hepatitis B virus among migrant workers from Cambodia, Laos, and Myanmar to Thailand[J].J Med Virol, 2010, 82 (8) :1341-1349.
    [45]Liu Z, Hou J.Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Dual Infection[J].Int J Med Sci, 2006, 3 (2) :57-62.
    [46]Irshad M, Peter S.Spectrum of viral hepatitis in thalassemic chil-dren receiving multiple blood transfusions[J].Indian J Gastroen-terol, 2002, 21 (5) :183-184.
    [47]Soriano V, Puoti M, Peters M, et al.Care of HIV patients with chronic hepatitis B:updated recommendations from the HIV-Hep-atitis B Virus International Panel[J].AIDS, 2008, 22 (12) :1399-1410.
    [48]Tounkara A, Sarro YS, Kristensen S, et al.Seroprevalence of HIV/HBV coinfection in Malian blood donors[J].J Int Assoc Physicians AIDS Care (Chic) , 2009, 8 (1) :47-51.
    [49]Nyirenda M, Beadsworth MB, Stephany P, et al.Prevalence of infec-tion with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi[J].J Infect, 2008, 57 (1) :72-77.
    • Relative Articles

  • Relative Articles

    [1]Shan SHAN, Lianhui ZHAO, Hong MA, Xiaojuan OU, Hong YOU, Jidong JIA. Definition, etiology, and epidemiology of liver cirrhosis[J]. Journal of Clinical Hepatology, 2021, 37(1): 14-16. doi: 10.3969/j.issn.1001-5256.2021.01.003
    [2]Huang BeiBei, Li Lei. Association between chronic hepatitis B and nonalcoholic fatty liver disease and pathogenesis of chronic hepatitis B with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2019, 35(4): 874-878. doi: 10.3969/j.issn.1001-5256.2019.04.037
    [3]Gu JiuLian, Liu ShouSheng, Li ChangFei, Xiao JianHan, Xin YongNing, Xuan ShiYing. Value of highly sensitive serum virological markers in hepatitis B patients with a low viral load[J]. Journal of Clinical Hepatology, 2018, 34(6): 1302-1307. doi: 10.3969/j.issn.1001-5256.2018.06.037
    [4]Wang HaiXia, Qi Yue. ‍Changes in serological markers of HBV during 4-year antiviral treatment with entecavir: A case report[J]. Journal of Clinical Hepatology, 2018, 34(12): 2648-2649. doi: 10.3969/j.issn.1001-5256.2018.12.027
    [5]Shi XinXing, Zhang YanQiong, Zhu Peng, Yan GuoHua, Zhang ZhangJiang, Wang YuMing. Prognostic risk factors in patients with hepatitis B virus- related acute- on- chronic liver failure[J]. Journal of Clinical Hepatology, 2016, 32(4): 700-705. doi: 10.3969/j.issn.1001-5256.2016.04.018
    [6]Jiang Ni, Mao XiaoRong, Peng XueBin, Li YueYue, Chen QiMing, Chen QingFeng. Analysis of factors influencing hepatitis C with thyroid dysfunction in Chinese patients[J]. Journal of Clinical Hepatology, 2015, 31(8): 1266-1270. doi: 10.3969/j.issn.1001-5256.2015.08.020
    [7]Xu XiuHua, Xiang XiaoXing, Long AiHua, Liu Dan, Wang JingSong. Differential distribution of age and HBV serological markers in liver cirrhosis and non-cirrhotic patients with primary liver cancer[J]. Journal of Clinical Hepatology, 2013, 29(3): 214-216.
    [8]Zhang DongQing, Chen Li, Gan QiaoRong, Zhou Rui, Huang JianRong, Pan Chen. Prognostic factors for hepatitis B acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2012, 28(10): 740-743.
    [9]Zhang JianJun, Wu LiPing, Du RuiQing, Wang JianBin, Yao ZhanCheng, Yu GuiQin. Factors correlating with the liver inflammation grade ≥G2 in chronic HBV-infected patients with normal liver function[J]. Journal of Clinical Hepatology, 2012, 28(1): 35-38.
    [10]Hui Wei, Xu Bin, Guo XinHui. Clinical study on glucose metabolic disorder in patients with diabetes and chronic hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2012, 28(7): 538-541.
    [11]Peng JianPing, Sun KeWei, Wu YuNan. Impact of early virological response to antiviral treatment on the outcomes of hepatitis B-associated liver failure [J]. Journal of Clinical Hepatology, 2012, 28(10): 752-755.
    [12]Zhou YouQian, Yin FengMing, Feng JingHua. Mode of acquisition of hepatitis C virus infection in patients from southern Hunan province hospitalized with chronic hepatitis C[J]. Journal of Clinical Hepatology, 2012, 28(6): 443-445.
    [13]Yuan JianGuo, Wang XinGuo, Cui Xia, Liu FengHua, Wang FengHua, Song JiKui, Zhao HongKui. The activation of rat hepatic stellate cells stimulated with hepatitis B virus in vitro[J]. Journal of Clinical Hepatology, 2011, 27(2): 163-165.
    [14]Zhuang Lin, You Jing, Lei Hua, Li YunLi, Kong Lei, Wang QingQing, Hu MingFen, Bo BaoLi. Study of liver pathology in mild ALT - elevated chronic hepatitis B patients with different HBV DNA levels[J]. Journal of Clinical Hepatology, 2011, 27(12): 1278-1281+1284.
    [15]Zhang LiJun, Jia XiaoFang, Teng ZhenLin, Cheng NengNeng. Biomarkers of liver cancer related to hepatitis B virus selected by proteomics[J]. Journal of Clinical Hepatology, 2011, 27(5): 553-557.
    [16]Yu Hui. Advances in epidemiology, diagnosis and treatment of hepatitis B in children[J]. Journal of Clinical Hepatology, 2011, 27(7): 687-689.
    [18]Zhou WenHong, Ying Hao. Analysis of the factors influencing the prognosis of chronic severe hepatitis B[J]. Journal of Clinical Hepatology, 2007, 23(1): 26-27.
    • Supplements(0)
    • Cited By
  • Created with Highcharts 5.0.7Amount of accessChart context menuAbstract Views, HTML Views, PDF Downloads StatisticsAbstract ViewsHTML ViewsPDF Downloads2024-042024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-0302.557.51012.515
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 2.6 %FULLTEXT: 2.6 %META: 85.7 %META: 85.7 %PDF: 11.7 %PDF: 11.7 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 5.9 %其他: 5.9 %其他: 0.3 %其他: 0.3 %Arlington: 0.3 %Arlington: 0.3 %Seattle: 0.3 %Seattle: 0.3 %上海: 4.9 %上海: 4.9 %北京: 7.8 %北京: 7.8 %南宁: 1.6 %南宁: 1.6 %台州: 0.3 %台州: 0.3 %吉林: 2.6 %吉林: 2.6 %广州: 2.0 %广州: 2.0 %张家口: 1.3 %张家口: 1.3 %成都: 2.6 %成都: 2.6 %昆明: 0.3 %昆明: 0.3 %杭州: 0.3 %杭州: 0.3 %桂林: 0.7 %桂林: 0.7 %武汉: 1.3 %武汉: 1.3 %湖州: 0.3 %湖州: 0.3 %福州: 0.3 %福州: 0.3 %绵阳: 0.3 %绵阳: 0.3 %芒廷维尤: 30.3 %芒廷维尤: 30.3 %苏州: 0.3 %苏州: 0.3 %莫斯科: 1.3 %莫斯科: 1.3 %西宁: 32.2 %西宁: 32.2 %长春: 1.0 %长春: 1.0 %香港: 1.3 %香港: 1.3 %其他其他ArlingtonSeattle上海北京南宁台州吉林广州张家口成都昆明杭州桂林武汉湖州福州绵阳芒廷维尤苏州莫斯科西宁长春香港

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (3206) PDF downloads(763) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[3111]YesterdayPV[5495]TodayIP[3200]TodayPV[5587]Online[114]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return